Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DTwP-HepB-Hib-IPV vaccine
- Development stage
- Unknown
- Lead developer
- LG Chem
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
DTwP-HepB-Hib-IPV vaccine is a hexavalent combination pediatric vaccine designed to protect against six major childhood diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and Haemophilus influenzae type b infections. The formulation combines whole-cell pertussis (wP) with inactivated poliovirus and recombinant hepatitis B surface antigen, along with diphtheria and tetanus toxoids and Hib polysaccharide conjugated to a carrier protein. The mechanism of action is immunostimulation—eliciting protective immune responses against each targeted pathogen. This combination reduces the number of injections required for infants and children, improving compliance and coverage rates. It is primarily used in routine immunization programs for infants[8].
- Brand names
- SHAN6SHAN-6SHAN 6
- Other names
- Diphtheria-Tetanus-Pertussis-Hepatitis B-Inactivated Poliovirus-Haemophilus influenzae type b vaccine
02
Targets
Poliovirus capsid proteinsHBsAg (Hepatitis B surface antigen)Diphtheria toxin
Beyond the preview
Go deeper on DTwP-HepB-Hib-IPV vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DTwP-HepB-Hib-IPV vaccine.